Nieborowska-Skorska M - Search Results

1

Ruxolitinib-induced defects in DNA repair cause sensitivity to PARP inhibitors in myeloproliferative neoplasms.

Nieborowska-Skorska M, Maifrede S, Dasgupta Y, Sullivan K, Flis S, Le BV, Solecka M, Belyaeva EA, Kubovcakova L, Nawrocki M, Kirschner M, Zhao H, Prchal JT, Piwocka K, Moliterno AR, Wasik M, Koschmieder S, Green TR, Skoda RC, Skorski T. Nieborowska-Skorska M, et al. Blood. 2017 Dec 28;130(26):2848-2859. doi: 10.1182/blood-2017-05-784942. Epub 2017 Oct 17. Blood. 2017. PMID: 29042365 Free PMC article.

2

A model of Ph' positive chronic myeloid leukemia-blast crisis cell line growth in immunodeficient SCID mice.

Skórski T, Nieborowska-Skórska M, Calabretta B. Skórski T, et al. Folia Histochem Cytobiol. 1992;30(3):91-6. Folia Histochem Cytobiol. 1992. PMID: 1286728

3

[Use of autologous bone marrow transplants in the treatment of neoplasms].

Nieborowska-Skórska M, Skórski T. Nieborowska-Skórska M, et al. Wiad Lek. 1988 Mar 15;41(6):383-9. Wiad Lek. 1988. PMID: 3066014 Review. Polish. No abstract available.

4

Leukemia treatment in severe combined immunodeficiency mice by antisense oligodeoxynucleotides targeting cooperating oncogenes.

Skorski T, Nieborowska-Skorska M, Campbell K, Iozzo RV, Zon G, Darzynkiewicz Z, Calabretta B. Skorski T, et al. J Exp Med. 1995 Dec 1;182(6):1645-53. doi: 10.1084/jem.182.6.1645. J Exp Med. 1995. PMID: 7500009 Free PMC article.

5

Phosphatidylinositol-3 kinase activity is regulated by BCR/ABL and is required for the growth of Philadelphia chromosome-positive cells.

Skorski T, Kanakaraj P, Nieborowska-Skorska M, Ratajczak MZ, Wen SC, Zon G, Gewirtz AM, Perussia B, Calabretta B. Skorski T, et al. Blood. 1995 Jul 15;86(2):726-36. Blood. 1995. PMID: 7606002 Free article.

6

The role of c-Myc protooncogene in chronic myelogenous leukemia.

Nieborowska-Skórska M, Ratajczak MZ, Calabretta B, Skórski T. Nieborowska-Skórska M, et al. Folia Histochem Cytobiol. 1994;32(4):231-4. Folia Histochem Cytobiol. 1994. PMID: 7758616

7

Oncogene-targeted antisense oligodeoxynucleotides combined with chemotherapy or immunotherapy: a new approach for tumor treatment?

Nieborowska-Skórska M, Nakashima M, Ratajczak M, Steplewski Z, Calabretta B, Skórski T. Nieborowska-Skórska M, et al. Folia Histochem Cytobiol. 1994;32(1):35-40. doi: 10.1007/BF02693351. Folia Histochem Cytobiol. 1994. PMID: 8026602

8

Successful mafosfamide purging of bone marrow from chronic myelogenous leukemia (CML) cells.

Nieborowska-Skórska M, Skórski T, Ratajczak MZ, Szczylik C, Malaguarnera L, Calabretta B. Nieborowska-Skórska M, et al. Folia Histochem Cytobiol. 1993;31(4):161-7. Folia Histochem Cytobiol. 1993. PMID: 8137996

9

Suppression of Philadelphia1 leukemia cell growth in mice by BCR-ABL antisense oligodeoxynucleotide.

Skorski T, Nieborowska-Skorska M, Nicolaides NC, Szczylik C, Iversen P, Iozzo RV, Zon G, Calabretta B. Skorski T, et al. Proc Natl Acad Sci U S A. 1994 May 10;91(10):4504-8. doi: 10.1073/pnas.91.10.4504. Proc Natl Acad Sci U S A. 1994. PMID: 8183938 Free PMC article.

10

Negative regulation of p120GAP GTPase promoting activity by p210bcr/abl: implication for RAS-dependent Philadelphia chromosome positive cell growth.

Skorski T, Kanakaraj P, Ku DH, Nieborowska-Skorska M, Canaani E, Zon G, Perussia B, Calabretta B. Skorski T, et al. J Exp Med. 1994 Jun 1;179(6):1855-65. doi: 10.1084/jem.179.6.1855. J Exp Med. 1994. PMID: 8195713 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73 results

Search Page

Filters